Jun 22, 2009 | HIV and Hepatitis
Newer Anti-HIV Drugs and How to Use Them: Part I
There are currently several new anti-HIV drugs that have been approved by the U.S. Food and Drug Administration or that are in clinical testing.
HIV Coinfection Has Little Effect on Response to Chronic Hepatitis B Treatment
Studies have consistently shown that HIV-HCV coinfected patients do not respond as well to interferon-based therapy as those with HCV monoinfection .
Apricitabine Trial Continues, With Changes
More Treatment News June 9, 2009 The experimental antiretroviral drug apricitabine has received approval from a data safety monitoring board to continue with its Phase III trial beyond week 16.
Gilead Fundamentally Strong By: Jason Napodano, CFA 0 ) Share Business continues to look strong for Gilead Sciences .
Also on Topix